5 New Diabetes Technologies and Treatments

Publication
Slideshow
Drug Topics JournalDrug Topics October 2019
Volume 163
Issue 10

Noteworthy diabetes management products and updates making waves this year.

Like other areas of healthcare, diabetes management in 2019 has been experiencing a combination of new device developments and improvements, technological advancements, new drug approvals, and new partnerships offering a glimpse of distant future possibilities. Here are five noteworthy products and updates that are making waves in the diabetes management space this year:

Download Issue PDF
Articles in this issue
statins heart rate
The Truth About Statins
color splash
Opinion: Color Coded Inhalers
tooth made out of pills
Pharmacist Collaborations Must Extend to Dentists
money in pill vial
Contemplating the Future of List Prices
New Drug Review: Tafamidis Meglumine for Cardiomyopathy
New Drug Review: Tafamidis Meglumine for Cardiomyopathy
genetics
Life-Altering Gene Therapy Pipeline Poses Challenges
empty pill bottles
Solving the Drug Shortage Burden
transgender hand with flag paint
Providing Healthcare to Transgender Patients
neon prep sign
State Laws May Determine Access to Pharmacy-based PrEP Clinics
Merger arrow
Official CVS/Aetna Merger: Greater Convenience, Less Cost Reform
Alternative Approaches to Opioids
Alternative Approaches to Opioids
diabetes
5 Types of Diabetes Patients Who Need More Management
5 New Diabetes Technologies and Treatments
5 New Diabetes Technologies and Treatments
woman holding stomach in pain
Lupus and Celiac Disease: What Pharmacists Need to Know
lefamulin product image
Lefamulin Could Be Vital in the Pneumonia Fight
Related Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
Related Content
COVID-19 Pandemic Exacerbated Functional Limitations Among Older Adults With Diabetes

COVID-19 Pandemic Exacerbated Functional Limitations Among Older Adults With Diabetes

April 17th 2024
Article

Overall, older adults with diabetes faced a 53% higher risk of developing at least 1 functional limitation during the pandemic compared to older adults without diabetes.

Looking to the Future of Independent Pharmacy

Looking to the Future of Independent Pharmacy

July 13th 2022
Podcast

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

GLP-1 Use Not Associated With Increased Thyroid Cancer Risk

GLP-1 Use Not Associated With Increased Thyroid Cancer Risk

April 16th 2024
Article

A study from the Karolinska Institutet found that 76 out of 145410 patients treated with a GLP-1 developed thyroid cancer during nearly 4 years of follow-up.

Easing The Burden of Burnout With Technology

Easing The Burden of Burnout With Technology

January 31st 2022
Podcast

Lani Bertrand, RPh, joins the latest episode of Over The Counter to discuss the role of technology in easing burnout during the COVID-19 pandemic.

Ozempic, Other GLP-1 Therapies Caused Major Increase in Medicare Spending

Ozempic, Other GLP-1 Therapies Caused Major Increase in Medicare Spending

March 29th 2024
Article

After semaglutide and tirzepatide were approved, and ozempic use continues to rise, Medicare spending is also increasing because of a high demand for GLP-1 therapies.

Comprehensive Medication Reviews Can Help Improve Adherence in Patients With T2D

Comprehensive Medication Reviews Can Help Improve Adherence in Patients With T2D

March 22nd 2024
Article

Medication therapy management can also increase the likelihood of using statins in this population.

© 2024 MJH Life Sciences

All rights reserved.